A double-blind crossover trial was conducted of thyrotropin releasing hormone 
treatment in six patients with amyotrophic lateral sclerosis. Patients received 
4 mg of thyrotropin releasing hormone intramuscularly daily during the two-week 
treatment period. Although three patients reported subjective improvement, 
objective evaluation failed to demonstrate therapeutic effectiveness of 
thyrotropin releasing hormone in this dosage.